ENMD-981693 Completed Phase 1 Trials for Advanced Malignant Neoplasm Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 1 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT00658671 | A Dose-Escalation Study of ENMD-2076 Administered Orally to Patients With Advanced Cancer |